Literature DB >> 24072415

The role of lipids and uremic toxins in cardiovascular disease in CKD.

Ziad A Massy1.   

Abstract

Lipid abnormalities and uremic toxins are features of chronic kidney disease (CKD) and may influence cardiovascular outcomes in CKD patients. Recent data suggest that uremic toxins may modulate lipoprotein levels and composition (e.g., oxidation or carbamylation) and enhance the cardiovascular toxicity of lipoproteins in CKD patients.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24072415     DOI： 10.1007/s10157-013-0864-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


  8 in total

Review 1.  Review on uremic toxins: classification, concentration, and interindividual variability.

Authors:  Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

Review 2.  LDL cholesterol in CKD--to treat or not to treat?

Authors:  Ziad A Massy; Dick de Zeeuw
Journal:  Kidney Int       Date:  2013-05-22       Impact factor: 10.612

Review 3.  Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease.

Authors:  Eugene O Apostolov; Alexei G Basnakian; Ercan Ok; Sudhir V Shah
Journal:  J Ren Nutr       Date:  2012-01       Impact factor: 3.655

4.  p-Cresyl sulfate promotes insulin resistance associated with CKD.

Authors:  Laetitia Koppe; Nicolas J Pillon; Roxane E Vella; Marine L Croze; Caroline C Pelletier; Stéphane Chambert; Ziad Massy; Griet Glorieux; Raymond Vanholder; Yann Dugenet; Hédi A Soula; Denis Fouque; Christophe O Soulage
Journal:  J Am Soc Nephrol       Date:  2013-01       Impact factor: 10.121

5.  Chronic uremia stimulates LDL carbamylation and atherosclerosis.

Authors:  Eugene O Apostolov; Debarti Ray; Alena V Savenka; Sudhir V Shah; Alexei G Basnakian
Journal:  J Am Soc Nephrol       Date:  2010-10-14       Impact factor: 10.121

6.  Upregulation of BAD, a pro-apoptotic protein of the BCL2 family, in vascular smooth muscle cells exposed to uremic conditions.

Authors:  Eric Trécherel; Corinne Godin; Christophe Louandre; Joyce Benchitrit; Sabrina Poirot; Jean-Claude Mazière; Ziad A Massy; Antoine Galmiche
Journal:  Biochem Biophys Res Commun       Date:  2011-12-08       Impact factor: 3.575

7.  Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure.

Authors:  Maria D'Apolito; Xueliang Du; Haihong Zong; Alessandra Catucci; Luigi Maiuri; Tiziana Trivisano; Massimo Pettoello-Mantovani; Angelo Campanozzi; Valeria Raia; Jeffrey E Pessin; Michael Brownlee; Ida Giardino
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

Review 8.  The role of oxidative stress in chronic kidney disease.

Authors:  Ziad A Massy; Peter Stenvinkel; Tilman B Drueke
Journal:  Semin Dial       Date:  2009 Jul-Aug       Impact factor: 3.455
  8 in total
  5 in total

Review 1.  Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins.

Authors:  Dustin R Walsh; Thomas D Nolin; Peter A Friedman
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

2.  Lipid Profile Is Negatively Associated with Uremic Toxins in Patients with Kidney Failure-A Tri-National Cohort.

Authors:  Sam Hobson; Henriette de Loor; Karolina Kublickiene; Joachim Beige; Pieter Evenepoel; Peter Stenvinkel; Thomas Ebert
Journal:  Toxins (Basel)       Date:  2022-06-16       Impact factor: 5.075

3.  Kidney Disease Symptoms before and after Kidney Transplantation.

Authors:  Kathryn Taylor; Nadia M Chu; Xiaomeng Chen; Zhan Shi; Eileen Rosello; Sneha Kunwar; Paul Butz; Silas P Norman; Deidra C Crews; Keiko I Greenberg; Aarti Mathur; Dorry L Segev; Tariq Shafi; Mara A McAdams-DeMarco
Journal:  Clin J Am Soc Nephrol       Date:  2021-06-18       Impact factor: 10.614

4.  Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.

Authors:  Christiane Drechsler; Sahir Kalim; Julia B Wenger; Pirianthini Suntharalingam; Tammy Hod; Ravi I Thadhani; S Ananth Karumanchi; Christoph Wanner; Anders H Berg
Journal:  Kidney Int       Date:  2015-02-11       Impact factor: 10.612

Review 5.  Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins.

Authors:  Nans Florens; Catherine Calzada; Egor Lyasko; Laurent Juillard; Christophe O Soulage
Journal:  Toxins (Basel)       Date:  2016-12-16       Impact factor: 4.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.